» Articles » PMID: 33821440

Unsaturated Fatty Acids As a Co-therapeutic Agents in Cancer Treatment

Overview
Journal Mol Biol Rep
Specialty Molecular Biology
Date 2021 Apr 6
PMID 33821440
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Chemotherapy is standard treatments for many malignancies. However, in most cases, this method is not able to induce apoptosis and in many cases, with cancer recurrence, leads to patient death. There are several procedure to control and suppress malignant cells, but among these methods, administration of ɷ-3 fatty acids and ɷ-6 fatty due to their destructive effects on cancer cells is more prominent. Many clinical studies have shown beneficial effects of ɷ-3 and ɷ-6 fatty acids in cardiovascular disorders, asthma, rheumatoid arthritis, osteoporosis and in most cancers such as colon, breast, prostate and other malignancies. Studies showed that polyunsaturated fatty acids (PUFAs) have a toxic effect on cancer cells. However, the exact mechanism of how ɷ- fatty acids affect cancer cells is still unknown. In this review alternative issues of malignancies co-treatments agents such as PUFAs have been studied. Also, the latest known PUFAs mechanisms on malignancies have been described.

Citing Articles

Prospecting Pharmacologically Active Biocompounds from the Amazon Rainforest: In Vitro Approaches, Mechanisms of Action Based on Chemical Structure, and Perspectives on Human Therapeutic Use.

de Almada-Vilhena A, Dos Santos O, Machado M, Nagamachi C, Pieczarka J Pharmaceuticals (Basel). 2024; 17(11).

PMID: 39598361 PMC: 11597570. DOI: 10.3390/ph17111449.


Fatty acid composition and anti-cancer activity of essential oil from larvae in combination with zoledronic acid on prostate cancer.

Askari N, Mansouri S Heliyon. 2024; 10(21):e40012.

PMID: 39583822 PMC: 11582447. DOI: 10.1016/j.heliyon.2024.e40012.


Inhibition of the NF-κB/HIF-1α signaling pathway in colorectal cancer by tyrosol: a gut microbiota-derived metabolite.

Guo J, Meng F, Hu R, Chen L, Chang J, Zhao K J Immunother Cancer. 2024; 12(9).

PMID: 39343509 PMC: 11440206. DOI: 10.1136/jitc-2024-008831.


Modulatory effects of miRNAs in doxorubicin resistance: A mechanistic view.

Meinag F, Fatahi M, Vahedian V, Maroufi N, Mosayyebi B, Ahmadi E Funct Integr Genomics. 2024; 24(5):150.

PMID: 39222264 DOI: 10.1007/s10142-024-01431-x.


Obesity and lipid metabolism in the development of osteoporosis (Review).

Wang X, Zhang C, Zhao G, Yang K, Tao L Int J Mol Med. 2024; 54(1).

PMID: 38818830 PMC: 11188977. DOI: 10.3892/ijmm.2024.5385.


References
1.
Chajes V, Bougnoux P . Omega-6/omega-3 polyunsaturated fatty acid ratio and cancer. World Rev Nutr Diet. 2003; 92:133-51. View

2.
Conklin K . Dietary polyunsaturated fatty acids: impact on cancer chemotherapy and radiation. Altern Med Rev. 2002; 7(1):4-21. View

3.
Hammamieh R, Chakraborty N, Miller S, Waddy E, Barmada M, Das R . Differential effects of omega-3 and omega-6 Fatty acids on gene expression in breast cancer cells. Breast Cancer Res Treat. 2006; 101(1):7-16. DOI: 10.1007/s10549-006-9269-x. View

4.
Reddy B, Sugie S . Effect of different levels of omega-3 and omega-6 fatty acids on azoxymethane-induced colon carcinogenesis in F344 rats. Cancer Res. 1988; 48(23):6642-7. View

5.
Shahidi F, Miraliakbari H . Omega-3 (n-3) fatty acids in health and disease: Part 1--cardiovascular disease and cancer. J Med Food. 2005; 7(4):387-401. DOI: 10.1089/jmf.2004.7.387. View